Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: A 5 yr study

British Journal of Anaesthesia

Volumn 108, Issue 3, 2012, Pages 452-459

  Bird, G T ^a   Farquhar Smith, P ^a   Wigmore, T ^a   Potter, M ^a   Gruber, P C ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

haematologic neoplasms; intensive care unit; prognosis

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; HYPERTENSIVE FACTOR; MELPHALAN;

ADULT; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CORRELATION ANALYSIS; DEMOGRAPHY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; MYCOSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; RISK FACTOR; THROMBOCYTE COUNT; WHOLE BODY RADIATION;

EID: 84857337457     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer449     Document Type: Article

References (40)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. [Internet] Lyon, France: International Agency for Research on Cancer, 2010. Available from: http://globocan.iarc.fr
2. Gordon AC, Oakervee HE, Kaya B, et al. Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care. Anaesthesia 2005; 60: 340-7 (Pubitemid 40450522)
3. Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ. Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy. Br Med J 1988; 296: 1025-9
4. Brunet F, Lanore JJ, Dhainaut JF, et al. Is intensive care justified for patients with haematological malignancies? Intensive Care Med1990; 16: 291-7 (Pubitemid 20253463)
5. Azoulay E, Recher C, Alberti C, et al. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 1999; 25: 1395-401
6. Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 2003; 31: 104-12 (Pubitemid 36151158)
7. Azoulay E, Alberti C, Bornstain C, et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 2001; 29: 519-25 (Pubitemid 32225292)
8. Cuthbertson BH, Rajalingham Y, Harrison S, McKirdy F. The outcome of haematological malignancy in Scottish intensive care units. J Intensive Care Soc 2008; 9: 135-40
9. Rees JKH, Gray RG, Wheatley K. Dose intensification in acute myleiod leukaemia: greater effectiveness at lower cost. Principal report of the medical research council's AML9 study. Br J Haematol 1996; 94: 89-98 (Pubitemid 26232545)
10. Azoulay E, Afessa B. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med 2006; 32: 3-5 (Pubitemid 43039368)
11. Hampshire PA, Welch CA, McCrossan LA, Francis K, Harrison DA. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 2009; 13: R137
12. Crawford SW, Petersen FB. Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Respir Dis 1992; 145: 510-4
13. Khassawneh BY, White P Jr, Anaissie EJ, Barlogie B, Hiller FC. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 2002; 121: 185-8 (Pubitemid 34114245)
14. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who required intensive care unit support. Mayo Clin Proc 1992; 67: 117-22
15. Yau E, Rohatiner AZ, Lister TA, Hinds CJ. Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy. Br J Cancer 1991; 64: 938-42
16. Owczuk R, Wujtewicz MA, Sawicka W, Wadrzyk A, Wujtewicz M. Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and nonsurvivors in intensive care unit. Support Care Cancer 2005; 13: 332-8 (Pubitemid 40674839)
17. Evison J, Rickenbacher P, Ritz R, et al. Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors. Swiss Med Wkly 2002; 131: 681-6
18. Lamia B, Hellot M, Girault C, et al. Changes in severity and organ failure scores as prognostic factors in oncohematological malignancy patients admitted to the ICU. Intensive Care Med 2006; 32: 1560-8 (Pubitemid 44484346)
19. Kroschinsky F, Weise M, Illmer T, et al. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 2002; 28: 1294-300 (Pubitemid 35025049)
20. Massion PB, Dive AM, Doyen C, et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 2002; 30: 2260-70 (Pubitemid 35191577)
21. Staudinger T, Stoiser B, Müllner M, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28: 1322-8 (Pubitemid 30324501)
22. Huaringa AJ, Leyva FJ, Giralt SA, et al. Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 2000; 28: 1014-7 (Pubitemid 30262071)
23. Lim ZY, Pagliuca A, Simpson S, et al. Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data. Br J Haematol 2007; 136: 448-50 (Pubitemid 46046303)
24. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858-73 (Pubitemid 38344143)
25. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29 (Pubitemid 15250137)
26. Lecuyer L, Chevret S, Guidet B, et al. Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J 2008; 32: 748-54
27. National Confidential Inquiry in Patient Outcome and Deaths. For better for worse? A review of the care of patients who died within receiving 30 days of systemic anti-cancer therapy, 2008
28. Linker C, Damon L, Ries C, Navarro W. Intensified and shortened cyclical chemotherapy for adult lymphoblastic leukaemia. J Clin Oncol 2002; 20: 2464-71 (Pubitemid 34525731)
29. Wossmann W, Schrappe M, Meyer U, Zimmermann M, Reiter A. Incidence of tumour lysis syndrome in children with advanced stage Burkitt's lymphoma/leukaemia before and after introduction of prophylactic use of urate oxidase. Ann Hematol 2003; 82: 160-5 (Pubitemid 36700996)
30. Ardeshna KM, Smith P, Norton A, et al. Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet 2003; 362: 516-22 (Pubitemid 36976715)
31. Kanda Y, Yamamoto R, Chizuka A, et al. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A met-analysis of 16 RCTs. Cancer 2000; 89: 1611-25
32. Hilbert G, Gruson D, Vargas F, et al. Non-invasive continuous positive airway pressure in neutropenic patients with acute respiratory failure requiring intensive care unit admission. Crit Care Med 2000; 28: 3185-90
33. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-8
34. Rivers E, Nguyen B, Havstad S, et al.; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77
35. Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808-14 (Pubitemid 46407795)
36. Thiery G, Azoulay E, Darmon M, et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23: 4406-13 (Pubitemid 46207015)
37. Blot F, Guiguet M, Nitenberg G, Leclercq B, Gachot B, Escudier B. Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer 1997; 33: 1031-7 (Pubitemid 27310777)
38. Benoit DD, Depuydt PO, Vandewoude KH, et al. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med 2006; 32: 93-9 (Pubitemid 43039382)
39. Hilbert G, Gruson D, Vargas F, et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481-7 (Pubitemid 32164899)
40. Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 1998; 158: 876-84 (Pubitemid 28449455)